Pharma Mar SA (PHMMF) Stock Statistics & Valuation Metrics
Total Valuation
Pharma Mar SA has a market cap or net worth of $1.34B. The enterprise value is $1.18B.
- Market Cap
- $1.34B
- Enterprise Value
- $1.18B
Share Statistics
Pharma Mar SA has 18,000,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 18,000,000
- Owned by Insiders
- ―
- Owned by Institutions
- 8.48%
Financial Efficiency
Pharma Mar SA’s return on equity (ROE) is 0.30 and return on invested capital (ROIC) is 12.83%.
- Return on Equity (ROE)
- 0.30
- Return on Assets (ROA)
- 0.19
- Return on Invested Capital (ROIC)
- 12.83%
- Return on Capital Employed (ROCE)
- 0.13
- Revenue Per Employee
- 438.40K
- Profits Per Employee
- 148.49K
- Employee Count
- 505
- Asset Turnover
- 0.56
- Inventory Turnover
- 0.24
Valuation Ratios
The current PE Ratio of Pharma Mar SA is 20.69. Pharma Mar SA’s PEG ratio is 0.56.
- PE Ratio
- 20.69
- PS Ratio
- 5.35
- PB Ratio
- 4.67
- Price to FCF
- 22.90
- Price to Operating Cash Flow
- 18.81
- PEG Ratio
- 0.56
Income Statement
In the last 12 months, Pharma Mar SA had revenue of 221.39M and earned 74.99M in profits. Earnings per share was 4.30.
- Revenue
- 221.39M
- Gross Profit
- 209.13M
- Operating Income
- 40.28M
- Pretax Income
- 59.65M
- Net Income
- 74.99M
- EBITDA
- 48.30M
- Earnings Per Share (EPS)
- 4.30
Cash Flow
In the last 12 months, operating cash flow was 62.21M and capital expenditures -11.11M, giving a free cash flow of 51.10M billion.
- Operating Cash Flow
- 62.21M
- Free Cash Flow
- 51.10M
- Free Cash Flow per Share
- 2.95
Dividends & Yields
Pharma Mar SA pays an annual dividend of $1.14, resulting in a dividend yield of 1.52%
- Dividend Per Share
- $1.14
- Dividend Yield
- 1.52%
- Payout Ratio
- 21.61%
- Free Cash Flow Yield
- 4.37%
- Earnings Yield
- 4.80%
Stock Price Statistics
- Beta
- 0.58
- 52-Week Price Change
- -12.35%
- 50-Day Moving Average
- 85.11
- 200-Day Moving Average
- 92.87
- Relative Strength Index (RSI)
- 34.12
- Average Volume (3m)
- 205
Important Dates
Pharma Mar SA upcoming earnings date is Mar 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 29, 2026
- Next Earnings Date
- Mar 01, 2027
- Ex-Dividend Date
- Jul 08, 2026
Financial Position
Pharma Mar SA as a current ratio of 3.02, with Debt / Equity ratio of 19.62%
- Current Ratio
- 3.02
- Quick Ratio
- 2.48
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- 0.65
- Interest Coverage Ratio
- 16.38
Taxes
In the past 12 months, Pharma Mar SA has paid -15.34M in taxes.
- Income Tax
- -15.34M
- Effective Tax Rate
- -0.26
Enterprise Valuation
Pharma Mar SA EV to EBITDA ratio is 27.78, with an EV/FCF ratio of 23.42.
- EV to Sales
- 5.47
- EV to EBITDA
- 27.78
- EV to Free Cash Flow
- 23.42
- EV to Operating Cash Flow
- 19.24
Balance Sheet
Pharma Mar SA has $168.88M in cash and marketable securities with $45.84M in debt, giving a net cash position of $123.04M billion.
- Cash & Marketable Securities
- $168.88M
- Total Debt
- $45.84M
- Net Cash
- $123.04M
- Net Cash Per Share
- $6.84
- Tangible Book Value Per Share
- $14.23
Margins
Gross margin is 90.57%, with operating margin of 14.93%, and net profit margin of 25.67%.
- Gross Margin
- 90.57%
- Operating Margin
- 14.93%
- Pretax Margin
- 18.66%
- Net Profit Margin
- 25.67%
- EBITDA Margin
- 19.71%
- EBIT Margin
- 15.94%
Analyst Forecast
The average price target for Pharma Mar SA is $112.06, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $112.06
- Price Target Upside
- 49.56% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- 23.38%
- EPS Growth Forecast
- 41.53%
Scores
- Smart Score
- 8
- AI Score
- ―